Evidence map›Paper›PMID 41159548›Full record

ArticleGigaScience2025

GTestimate: improving relative gene expression estimation in scRNA-seq using the Good-Turing estimator.

Martin Fahrenberger, Christopher Esk, Jürgen A Knoblich, Arndt von Haeseler

Abstract read
In one paragraph

Article in GigaScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Martin FahrenbergerCenter for Integrative Bioinformatics Vienna (CIBIV), Max Perutz Labs, University of Vienna and Medical University of Vienna, Vienna BioCenter (VBC), 1030 Vienna, Austria.ORCID 0000-0003-1107-0197
Christopher EskInstitute of Molecular Biology, University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0003-1833-0801
Jürgen A KnoblichInstitute of Molecular Biotechnology of the Austrian Academy of Science (IMBA), Vienna BioCenter (VBC), 1030 Vienna, Austria.ORCID 0000-0002-6751-3404
Arndt von HaeselerLudwig Boltzmann Institute for Network Medicine, University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-3366-4458

Funding

Austrian Science FundEuropean Commission H2020-MSCA-ITN-2017-765104
6 · The paper itself

Abstract

backgroundSingle-cell RNA-seq suffers from unwanted technical variation between cells, caused by its complex experiments and shallow sequencing depths. Many conventional normalization methods try to remove this variation by calculating the relative gene expression per cell. However, their choice of the maximum likelihood estimator is not ideal for this application.

resultsWe present GTestimate, a new normalization method based on the Good-Turing estimator, which improves upon conventional normalization methods by accounting for unobserved genes. To validate GTestimate, we developed a novel cell-targeted PCR amplification approach (cta-seq), which enables ultra-deep sequencing of single cells. Based on these data, we show that the Good-Turing estimator improves relative gene expression estimation and cell-cell distance estimation. Finally, we use GTestimate's compatibility with Seurat workflows to explore 4 example datasets and show how it can improve downstream results.

conclusionBy choosing a more suitable estimator for the relative gene expression per cell, we were able to improve scRNA-seq normalization, with potentially large implications for downstream results. GTestimate is available as an easy-to-use R-package and compatible with a variety of workflows, which should enable widespread adoption.

Indexed as

Gene Expression ProfilingRNA-SeqSequence Analysis, RNASingle-Cell AnalysisAlgorithmsAnimalsHigh-Throughput Nucleotide SequencingHumansSingle-Cell Gene Expression AnalysisSoftwaredeep sequencinggene expressionGood–Turing estimatornormalizationscRNA-seqtargeted amplification

Identifiers

PMID41159548
PMCPMC12569601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.